Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113281662 | 11328166 | 2 | F | 20150406 | 20160822 | 20150731 | 20160829 | EXP | FR-RECKITT BENCKISER PHARMACEUTICAL, INC-RB-081613-2015 | INDIVIOR | 46.64 | YR | M | Y | 71.00000 | KG | 20160829 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113281662 | 11328166 | 1 | PS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | Oral | 4 MG, DAILY | UNKNOWN | 20732 | SUBLINGUAL TABLET | ||||||||
| 113281662 | 11328166 | 2 | SS | THERALENE | TRIMEPRAZINE | 1 | Oral | 250 MG IN TOTAL (1 DAY) | Y | UNKNOWN | 0 | ||||||||
| 113281662 | 11328166 | 3 | SS | VALIUM | DIAZEPAM | 1 | Oral | 300 MG IN TOTAL (1 DAY) | Y | U | UNKNOWN | 0 | |||||||
| 113281662 | 11328166 | 4 | C | CANNABIS | CANNABIS SATIVA SUBSP. INDICA TOP | 1 | Unknown | UNK | U | U | UNKNOWN | 0 | |||||||
| 113281662 | 11328166 | 5 | C | COCAINE /00157602/ | COCAINE | 1 | Unknown | UNK | U | U | UNKNOWN | 0 | |||||||
| 113281662 | 11328166 | 6 | C | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 113281662 | 11328166 | 7 | C | NOZINAN /00038601/ | LEVOMEPROMAZINE | 1 | Unknown | UNK | 0 | ||||||||||
| 113281662 | 11328166 | 8 | C | SERESTA | OXAZEPAM | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113281662 | 11328166 | 1 | Product used for unknown indication |
| 113281662 | 11328166 | 2 | Product used for unknown indication |
| 113281662 | 11328166 | 3 | Product used for unknown indication |
| 113281662 | 11328166 | 4 | Product used for unknown indication |
| 113281662 | 11328166 | 5 | Product used for unknown indication |
| 113281662 | 11328166 | 6 | Product used for unknown indication |
| 113281662 | 11328166 | 7 | Product used for unknown indication |
| 113281662 | 11328166 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113281662 | 11328166 | HO |
| 113281662 | 11328166 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113281662 | 11328166 | Aggression | |
| 113281662 | 11328166 | Altered state of consciousness | |
| 113281662 | 11328166 | Bradycardia | |
| 113281662 | 11328166 | Drug abuse | |
| 113281662 | 11328166 | Miosis | |
| 113281662 | 11328166 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113281662 | 11328166 | 2 | 20150406 | 20150406 | 0 | |
| 113281662 | 11328166 | 3 | 20150406 | 20150406 | 0 |